PT141 (Bremelanotide) is a melanocortin receptor agonist studied extensively in research for its centrally acting effects on sexual arousal and dysfunction pathways. By targeting MC3R and MC4R in the hypothalamus, PT141 influences sexual motivation circuits independently of peripheral hemodynamic mechanisms, making it distinct from vascular-acting compounds. Preclinical and clinical research has investigated PT141 for its effects on sexual arousal in both male and female models, hypothalamic dopaminergic signaling, and motivation biology. PeptideBull provides PT141 at confirmed research-grade purity. Not intended for human or veterinary consumption.